Many elderly patients with metastatic renal cell carcinoma benefit from targeted therapies

PHILADELPHIA–Many elderly patients with metastatic renal cell carcinoma (RCC)–who are often underrepresented in clinical trials to treat the kidney cancer–are seeing overall survival benefits from treatment with targeted therapies, according to a new study from Penn Medicine researchers published this month in JAMA Network Open. Analyzing 13 years of data on Medicare patients, the study…

More than 5 million cancer survivors experience chronic pain, twice the rate of the general population

More than 5 million cancer survivors in the United States experience chronic pain, almost twice the rate in the general population, according to a study published by Mount Sinai researchers in JAMA Oncology in June. Researchers used the National Health Interview Survey, a large national representative dataset from the U.S. Centers for Disease Control and…